Left ventricular hypertrophy is associated with overexpression of HSP60, TLR2, and TLR4 in the myocardium

References

• Catalucci D, Latronico MVG, Ellingsen O, et al. Physiological myocardial hypertrophy: how and why? Front Biosci. 2008;13(13):312–324.
   PubMed Web of Science ®Google Scholar
• Stanton T, Dunn FG. Hypertension, left ventricular hypertrophy, and myocardial ischemia. Med Clin North Am. 2017;101(1):29–41.
   PubMed Web of Science ®Google Scholar
• Tham YK, Bernardo BC, Ooi JYY, et al. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch Toxicol. 2015;89(9):1401–1438.
   PubMed Web of Science ®Google Scholar
• Tseng ZH, Olgin JE, Vittinghoff E, et al. Prospective countywide surveillance and autopsy characterization of sudden cardiac death: POST SCD study. Circulation. 2018;137(25):2689–2700.
   PubMed Web of Science ®Google Scholar
• Rosca MG, Tandler B, Hoppel CL. Mitochondria in cardiac hypertrophy and heart failure. J Mol Cell Cardiol. 2013;55:31–41.
   PubMed Web of Science ®Google Scholar
• Zhang J. Myocardial energetics in cardiac hypertrophy. Clin Exp Pharmacol Physiol. 2002;29(4):351–359.
   PubMed Web of Science ®Google Scholar
• Meng Q, Li BX, Xiao X. Toward developing chemical modulators of hsp60 as potential therapeutics. Front Mol Biosci. 2018;5:35.
   PubMed Web of Science ®Google Scholar
• Lin KM, Lin B, Lian IY, et al. Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation. 2001;103(13):1787–1792.
   PubMed Web of Science ®Google Scholar
• Kirchhoff SR, Gupta S, Knowlton AA. Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation. 2002;105(24):2899–2904.
   PubMed Web of Science ®Google Scholar
• Gupta S, Knowlton AA. Cytosolic heat shock protein 60, hypoxia, and apoptosis. Circulation. 2002;106(21):2727–2733.
   PubMed Web of Science ®Google Scholar
• Knowlton A, Gupta S. HSP60, Bax, and cardiac apoptosis. Cardiovasc Toxicol. 2003;3(3):263–268.
   PubMedGoogle Scholar
• Gupta S, Knowlton AA. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol. 2007;292(6):H3052–6.
   PubMed Web of Science ®Google Scholar
• Graham PA, Ruhia W, Carola L, et al. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension. 2000;36:303–307.
   PubMed Web of Science ®Google Scholar
• Ohashi K, Burkart V, Flohe S, et al. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol. 2000;164(2):558–561.
   PubMed Web of Science ®Google Scholar
• Mitchell JA, Ryffel B, Quesniaux VFJ, et al. Role of pattern-recognition receptors in cardiovascular health and disease. Biochem Soc Trans. 2007;35(6):1449–1452.
   PubMed Web of Science ®Google Scholar
• Yang Y, Lv J, Jiang S, et al. The emerging role of Toll-like receptor 4 in myocardial inflammation. Cell Death Dis. 2016;7(5):e2234–e2234.
   PubMed Web of Science ®Google Scholar
• Yu L, Feng Z. The role of toll-like receptor signaling in the progression of heart failure. Mediators Inflamm. 2018;2018:1–11.
   Google Scholar
• Tian J, Guo X, Liu X-M, et al. Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes. Cardiovasc Res. 2013;98(3):391–401.
   PubMed Web of Science ®Google Scholar
• Li F, Zhang H, Yang L, et al. NLRP3 deficiency accelerates pressure overload-induced cardiac remodeling via increased TLR4 expression. J Mol Med. 2018;96(11):1189–1202.
   PubMed Web of Science ®Google Scholar
• Ehrentraut H, Felix Ehrentraut S, Boehm O, et al. Tlr4 deficiency protects against cardiac pressure overload induced hyperinflammation. PLOS One. 2015;10(11):e0142921.
   PubMed Web of Science ®Google Scholar
• Basso C, , Aguilera B, Banner J, et al. Guidelines for autopsy investigation of sudden cardiac death: 2017 update from the Association for European Cardiovascular Pathology. Virchows Arch. 2017;471(6):691–705.
   PubMed Web of Science ®Google Scholar
• Mrakovcic-Sutic I, Jakovac H, Simin M, et al. Heat shock protein-GP96 as an innate sensor of damage and activator of autoreactive NKT and regulatory T cells during liver regeneration. Histol Histopathol. 2008;23:1111–1126.
   PubMed Web of Science ®Google Scholar
• Jakovac H, Grubić Kezele T, Radošević-Stašić B. Expression profiles of metallothionein I/II and megalin in cuprizone model of de- and remyelination. Neuroscience. 2018;388:69–86.
   PubMed Web of Science ®Google Scholar
• Li Y, Si R, Feng Y, et al. Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and Toll-like receptor 4. J Biol Chem. 2011;286(36):31308–31319.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen L, Hagiwara N, et al. Regulation of heat shock protein 60 and 72 expression in the failing heart. J Mol Cell Cardiol. 2010;48(2):360–366.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang Y, Cao Z-Y, et al. Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction. J Cell Mol Med. 2015;19(12):2728–2740.
   PubMed Web of Science ®Google Scholar
• Panneerselvam L, Raghunath A, Perumal E. Differential expression of myocardial heat shock proteins in rats acutely exposed to fluoride. Cell Stress Chaperones. 2017;22(5):743–750.
   PubMed Web of Science ®Google Scholar
• Knowlton AA. Paying for the tolls: the high cost of the innate immune system for the cardiac myocyte. Adv Exp Med Biol. 2017;1003:17–34.
   PubMed Web of Science ®Google Scholar
• Malik ZA, Kott KS, Poe AJ, et al. Cardiac myocyte exosomes: stability, HSP60, and proteomics. Am J Physiol Heart Circ Physiol. 2013;304(7):H954–65.
   PubMed Web of Science ®Google Scholar
• Bonanad C, Nunez J, Sanchis J, et al. Serum heat shock protein 60 in acute heart failure: a new biomarker?. Congest Heart Fail. 2013;19(1):6–10.
   PubMedGoogle Scholar
• Matsuda S, Umemoto S, Yoshimura K, et al. Angiotensin activates MCP-1 and induces cardiac hypertrophy and dysfunction via toll-like receptor 4. J Atheroscler Thromb. 2015;22(8):833–844.
   PubMed Web of Science ®Google Scholar
• Katare PB, Bagul PK, Dinda AK, et al. Toll-like receptor 4 inhibition improves oxidative stress and mitochondrial health in isoproterenol-induced cardiac hypertrophy in rats. Front Immunol. 2017;8:719.
   PubMed Web of Science ®Google Scholar
• Monnerat-Cahli G, Alonso H, Gallego M, et al. Toll-like receptor 4 activation promotes cardiac arrhythmias by decreasing the transient outward potassium current (Ito) through an IRF3-dependent and MyD88-independent pathway. J Mol Cell Cardiol. 2014;76:116–125.
   PubMed Web of Science ®Google Scholar
• Chen T-H, Liu S-W, Chen M-R, et al. Neonatal death and heart failure in mouse with transgenic HSP60 expression. Biomed Res Int. 2015;2015:539805.
   PubMed Web of Science ®Google Scholar